Literature DB >> 33668091

Thrombocytopathies: Not Just Aggregation Defects-The Clinical Relevance of Procoagulant Platelets.

Alessandro Aliotta1, Debora Bertaggia Calderara1, Maxime G Zermatten1, Matteo Marchetti1,2, Lorenzo Alberio1.   

Abstract

Platelets are active key players in haemostasis. Qualitative platelet dysfunctions result in thrombocytopathies variously characterized by defects of their adhesive and procoagulant activation endpoints. In this review, we summarize the traditional platelet defects in adhesion, secretion, and aggregation. In addition, we review the current knowledge about procoagulant platelets, focusing on their role in bleeding or thrombotic pathologies and their pharmaceutical modulation. Procoagulant activity is an important feature of platelet activation, which should be specifically evaluated during the investigation of a suspected thrombocytopathy.

Entities:  

Keywords:  activation endpoints; platelet disorders; procoagulant platelets; thrombocytopathy

Year:  2021        PMID: 33668091     DOI: 10.3390/jcm10050894

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  3 in total

Review 1.  Platelets' Role in Dentistry: From Oral Pathology to Regenerative Potential.

Authors:  Serena Bianchi; Diana Torge; Fabiola Rinaldi; Maurizio Piattelli; Sara Bernardi; Giuseppe Varvara
Journal:  Biomedicines       Date:  2022-01-20

Review 2.  Mechanisms Underlying Dichotomous Procoagulant COAT Platelet Generation-A Conceptual Review Summarizing Current Knowledge.

Authors:  Lucas Veuthey; Alessandro Aliotta; Debora Bertaggia Calderara; Cindy Pereira Portela; Lorenzo Alberio
Journal:  Int J Mol Sci       Date:  2022-02-25       Impact factor: 5.923

3.  Low COAT platelets are frequent in patients with bleeding disorders of unknown cause (BDUC) and can be enhanced by DDAVP.

Authors:  Amandine Segot; Marcel Adler; Alessandro Aliotta; Elena Matthey-Guirao; Michael Nagler; Debora Bertaggia Calderara; Francesco Grandoni; Francisco J Gomez; Lorenzo Alberio
Journal:  J Thromb Haemost       Date:  2022-03-13       Impact factor: 16.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.